Recombinant Mouse LILRA6 Protein (Gly24-Asn629), C-mFc-tagged

Product Description

Cat

IMP-9958

Official Symbol

Lilra6

Product Overview

Recombinant Mouse LILRA6/CD85b/ILT8 protein (Gly24-Asn629) with a Mouse IgG2a (Glu98-Lys330) Fc tag at C-terminus was expressed in Mouse myeloma cell line.

Description

Predicted to enable inhibitory MHC class I receptor activity. Predicted to be involved in cytokine-mediated signaling pathway. Predicted to be integral component of membrane. Predicted to be active in plasma membrane.

Expression System

Mouse myeloma cell line

Species

Mouse

Tag

C-mFc

Predicted N Terminal

Gly24

Form

Lyophilized from a 0.2 μm filtered solution in MES and NaCl.

Molecular Mass

Predicted Molecular Mass: 95 kDa
SDS-PAGE: 97-118 kDa, reducing conditions

Protein length

Gly24-Asn629

Bio-activity

Measured by its binding ability in a functional ELISA. When Recombinant Human Angiopoietin-like Protein 7/ANGPTL7 is coated at 2 μg/mL, Recombinant Mouse LILRA6/CD85b Fc Chimera binds with an ED50 = 5-30 ng/mL.

Endotoxin

<0.10 EU/μg of the protein by the LAL method.

Purity

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.

Notes

Disulfide-linked homodimer

Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70 centigrade as supplied.
1 month, 2 to 8 centigrade under sterile conditions after reconstitution.
3 months, -20 to -70 centigrade under sterile conditions after reconstitution.

Reconstitution

Reconstitute at 250 μg/mL in PBS.

Bioactivity-ELISA 1

Data Sheet MSDS

Datasheet MSDS

For research or industrial raw materials, not for personal medical use!

Online Inquiry